Clinical trials
Phase 1/2 Prostatic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 6 |
| Completed | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Fujian Medical University | 5 |
| Jiangsu HengRui Medicine Co., Ltd. | 5 |
| AstraZeneca | 3 |
| Essen Biotech | 2 |
| Acerand Therapeutics (Shanghai) Limited | 1 |
| Beijing Biotech | 1 |
| Bivision Pharmaceuticals, Inc. | 1 |
| C Ray Therapeutics | 1 |
| DualityBio Inc. | 1 |
| Evopoint Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 36 |
| Ovarian Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Pancreatic Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Colorectal Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Glioblastoma | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.